These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 36161043)

  • 41. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!
    Scarpignato C
    Neurogastroenterol Motil; 2012 Aug; 24(8):697-704. PubMed ID: 22783985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gastroesophageal reflux].
    Schwizer W; Fried M
    Ther Umsch; 1997 Nov; 54(11):611-6. PubMed ID: 9454361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased prandial air swallowing and postprandial gas-liquid reflux among patients refractory to proton pump inhibitor therapy.
    Bravi I; Woodland P; Gill RS; Al-Zinaty M; Bredenoord AJ; Sifrim D
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):784-9. PubMed ID: 23376324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.
    Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K
    BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy.
    Kikuchi H; Fukuda S; Koike T; Shimodaira Y; Watanabe K; Saito M; Nakagawa K; Hatta W; Masamune A; Iijima K
    Esophagus; 2021 Apr; 18(2):380-387. PubMed ID: 32737802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers].
    Choi YJ
    Korean J Gastroenterol; 2022 Dec; 80(6):247-253. PubMed ID: 36567437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.
    Zerbib F; Bredenoord AJ; Fass R; Kahrilas PJ; Roman S; Savarino E; Sifrim D; Vaezi M; Yadlapati R; Gyawali CP
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14075. PubMed ID: 33368919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
    Kawara F; Fujita T; Morita Y; Uda A; Masuda A; Saito M; Ooi M; Ishida T; Kondo Y; Yoshida S; Okuno T; Yano Y; Yoshida M; Kutsumi H; Hayakumo T; Yamashita K; Hirano T; Hirai M; Azuma T
    World J Gastroenterol; 2017 Mar; 23(11):2060-2067. PubMed ID: 28373773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
    Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
    Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Gastroesophageal Reflux Disease.
    Gyawali CP; Fass R
    Gastroenterology; 2018 Jan; 154(2):302-318. PubMed ID: 28827081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of severe gastroesophageal reflux disease.
    DiPalma JA
    J Clin Gastroenterol; 2001 Jan; 32(1):19-26. PubMed ID: 11154163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
    Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H
    Digestion; 2024; 105(1):5-10. PubMed ID: 37591209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas PJ; Keefer L; Pandolfino JE
    Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.